Medacta Group SA (LON:0A05)

London flag London · Delayed Price · Currency is GBP · Price in CHF
147.20
-0.20 (-0.13%)
Feb 12, 2026, 4:31 PM GMT
Market Cap2.79B +42.5%
Revenue (ttm)553.81M +18.7%
Net Income81.38M +68.9%
EPS4.08 +69.5%
Shares Outn/a
PE Ratio34.33
Forward PE32.60
Dividend0.63 (0.41%)
Ex-Dividend DateMay 9, 2025
Volume1,104
Average Volume3,784
Open148.20
Previous Close147.40
Day's Range147.20 - 149.10
52-Week Range104.40 - 176.60
Beta1.18
RSI33.46
Earnings DateMar 13, 2026

About Medacta Group

Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. Medacta Group SA was founded in 1958 and is headquartered in Castel San Pietro, Switzerland. [Read more]

Industry Medical - Equipment & Services
Sector Healthcare
Founded 1958
Employees 2,041
Stock Exchange London Stock Exchange
Ticker Symbol 0A05
Full Company Profile

Financial Performance

In 2024, Medacta Group's revenue was 590.58 million, an increase of 15.62% compared to the previous year's 510.78 million. Earnings were 72.89 million, an increase of 53.89%.

Financial numbers in EUR Financial Statements